SESSION D5. The Heart of the Matter: Cardiac Disease in Pregnancy Brad M. Dolinsky, MD, MFM

Size: px
Start display at page:

Download "SESSION D5. The Heart of the Matter: Cardiac Disease in Pregnancy Brad M. Dolinsky, MD, MFM"

Transcription

1 37th Annual Advanced Practice in Primary and Acute Care Conference: October 9-11, :45 SESSION D5 Session Description: The Heart of the Matter: Cardiac Disease in Pregnancy Brad M. Dolinsky, MD, MFM S E S S I O N D5 Cardiac disease in pregnancy can be a complex milieu of physiology and seem overwhelming. The effects of the disease on the pregnancy, and the pregnancy on the disease can be complex. This lecture will attempt to review cardiac diseases seen in pregnancy, provide a tool for counseling patients with cardiac disease in pregnancy, and provide a tool for rapid management of hypertension in pregnancy. Learning Objectives: Following my presentation, participants will be able to: 1. Identify cardiac lesions that are amenable to drops in systemic vascular resistance. 2. Review a rapid assessment to risk stratify pregnant patients with cardiac disease. 3. Review management of hypertension in pregnancy.

2 Clinical Pearls for Cardiovascular Disease in Pregnancy The Heart of The Matter: Cardiac Disease in Pregnancy Provide general overview of cardiac physiologic changes in pregnancy Review common cardiac diseases seen clinically Provide a tool for counseling patients with known structural cardiac disease Review breakdown of lesions that are amenable to decrease in systemic vascular resistance Provide a rapid tool for management of hypertensive emergency Increase in Heart rate (about 20%) Increase in Cardiac Output (40%) Increase in Blood Volume (50%) Decrease in SVR(20%) Goals Physiologic adapatations Cardiac output INCREASES In Labor During Valsalva With pain With infection(chorio) High cardiac output state immediately after delivery of placenta and for 4 weeks Cardiac output decreases by 20% when supine, and 16% in dorsal lith Five principles of pregnancy that complicate cardiac disease of pregnancy Decreased SVR Increase in intravascular volume Postpartum increase in intravascular volume from auto-transfusion of blood from the contraction of uterus and mobilization of fluid Hypercoaguable Increase in CO during parturition 1

3 General management Activity modification (avoid bedrest though) Treat co-existing medical conditions(anemia/htn/thyroid disease) Collaborative care Labor in lateral decubitous Pain control, minimize hypotension O2 as necessary General management continued Invasive monitoring w/ PAC-reserve for sickest patients such as those with critical AS and Pulmonary HTN. TEE used more recently to guide fluid management. Cesarean delivery for obstetric indication (exception is a recent MI within 1 week) Class I-asymptomatic with greater than normal activity Class II-symptomatic with greater than normal activity(stairs) Class III-symptomatic with normal activity(walking) Class IV-symptomatic at rest New York Heart Association classification The Good-Minimal mortality (<1%) ASD VSD Pulmonic or Tricuspid valve disease Corrected TOF Bioprosthetic heart valve Mitral Stenosis NYHA I and II Marfan syndrome normal aorta Aortic or mitral insufficiency Hypertrophic cardiomyopathy (IHSS) The Good, Bad, and Ugly The Bad-5-15% mortality Mitral Stenosis NYHA III and IV Artifical heart valve Aortic stenosis Coarctation of aorta Uncorrected TOF MI The Ugly- >25% mortality Pulmonary Hypertension Coarctation-complicated Marfan aortic root dilation Dilated Cardiomyopathy The Good, Bad, and Ugly The Good, Bad, and Ugly 2

4 Marfan syndrome The Root of the Problem At risk for Aortic root aneurysm Aortic root >4cm, in preconception period, pregnancy is contraindicated <5 % vs about 10-25% risk for mortality Avoid hypertension Beta-blockade (long term use slows blockade), serial echocardiograms Early epidural use in labor Controversy on management of >4cm in pregnancy Eisenmenger s syndrome/pulmonary HTN 30% of women have a false diagnosis by echo (PA pressures >30mm Hg) When in doubt, in labor, pulmonary artery catheter Eisenmenger s-maternal death is high from hypoxemia and Pulmonary Embolism Cardiac Diseases Cardiac Diseases Eisenmenger s syndrome/pulmonary HTN Hypotension- reverse the shunt to right to left - avoided Run wet Use agents that decrease pulmonary vascular resistance w/ sparing of SVR IV prostocycline, nitric oxide Mitral Stenosis Generally good prognosis if MV is >1.5cm Stenosis less than this LV filling limited Fixed cardiac output Pulmonary edema Cardiac Diseases Mitral Stenosis Tachycardia should be avoided (short acting beta blockade goal HR ). Improves diastolic filling Normal wedge is 6-9mm Hg, MS patients need predelivery target of 14mmHg to maintain left ventricular filling Patients with moderate stenosis and only mild fluid overload, can be managed w/ fluid restriction Mitral Stenosis percutaneous baloon valvuloplasty can safely be performed in pregnancy 3

5 Aortic Stenosis Mortality related to degree of stenosis- >100mm Hg shunt is associated w/ 15-20% mortality. Hypotension and decreased preload can lead to drop in cardiac output (avoid) May consider PAC for goal of 15-17mm Hg Hypovolemia is more dangerous than pulmonary edema Peripartum cardiomyopathy Cardiomyopathy with EF<45% during last 4 weeks and 5 months postpartum without an identifiable cause Management- serial echo Antepartum- diuretics, afterload reduction (hydralazine and or beta blockers) Postpartum-ACE inhibitors May need digoxin antepartum or postpartum Cardiac Diseases Cardiac Diseases Peripartum cardiomyopathy Consider PAC for severe patients antepartum with EF <35%, may also consider VTE prophylaxis Future- echo after recovery predicts outcome in subsequent pregnancy normal echo may have a 21% risk for CHF in future pregnancy, but less than 5% risk of maternal death Mrs Smith presents for preconception counseling 23 year-old Gravida 0 History of a cardiac disease structural Repaired as a child What are the risks to her getting pregnant? Case Patients have multiple problems Which problem is more important? How does the combined problem correlate with my patient sitting in front of me? How do you counsel this patient sitting in front of you? Case Case 4

6 N O P E Risk for an Event Event defined as pulmonary edema, arrhythmia, stroke, death N NYHA >2 Positive= 1 point O = Obstruction (Left heart obstruction) MV<2cm or AV<1.5cm or Gradient across valve >30mm Any of these positive =1 point P Prior event (prior to pregnancy) Any = 1 point E Ejection Fraction <40% Positive= 1 point 5

7 Risk for event with 0 points=5% 1 point=27% > 1 point= NOPE (Don t get pregnant) 75% Divide lesions that tolerate a decrease in systemic vascular resistance vs those that do not Why is this important? Can they get an epidural or spinal or not? Cardiac Lesions and Decrease in SVR But there are so many lesions C A T P I E Cardiac Lesions and Decerease in SVR Cardiac Lesions that do not tolerate epidural/spinal Coarctation of Aorta Aortic Stenosis Tetralogy of Fallot (uncorrected) Pulmonary hypertension IHSS (Idiopathic Hypertrophic Subaortic Stenosis) Eisenmenger syndrome CATPIE lesions Bad-go on leave, give to your partner Decrease in SVR(epidural, blood loss, hypotension) not well tolerated Run wet, risk of pulmonary edema, but worse risk for hypoperfusion(syncope, cardiac ischemia, stroke) 6

8 Blood pressure? What is this? What are the components of this? BP=Flow X Resistance Elevated flow is from too much volume Causes: Fluid Hypercontractility Corticosteroids Increased work of heart Resistance is from too much vasoconstriction Causes: Catecholemines Hypocarbia Pheo Thyroid Cocaine Pregnancy HTN is either a flow problem or a resistance problem How do you treat a flow/volume problem? How do you treat a resistance problem? Volume problem Beta blocker or diuretic 7

9 Resistance problem Afterload reduction or vasodilators Assumption of a normal pregnancy heart DBP reflects degree of vasoconstriction 130/100 suggests vasoconstriction as a cause of the hypertension Gestalt of the Blood Pressure SBP- DBP= Pulse pressure Increased PP suggests a volume problem(hyperdynamic or fluid overload) What is ELEVATED PULSE PRESSURE? Speed limit is 55 Decreased (Narrow)PP suggests a vasoconstriction problem Gestalt of the Blood Pressure Gestalt of the Blood Pressure Examples 160/110 What is the pulse pressure? How would you calculate? How would you treat this? 190/100 What is the pulse pressure? How would you calculate? How would you treat this patient? Gestalt of the Blood Pressure Gestalt of the Blood Pressure 8

10 QUIZ TIME What is NOPE? What are the lesions that can not get a spinal? Clinical pearl Type I DM presenting in DKA with end organ damage What should be considered??? 9

Maternal Cardiac Disease In Pregnancy. August 25, 2017 PREGNANCY ECHO CONFERENCE

Maternal Cardiac Disease In Pregnancy. August 25, 2017 PREGNANCY ECHO CONFERENCE Maternal Cardiac Disease In Pregnancy August 25, 2017 PREGNANCY ECHO CONFERENCE Maternal Physiology Cardiac Output = HR x SV Non-pregnant: 4.5 L/min Pregnant: 6.0 L/min Increase most acute in first 10

More information

More History. Organization. Maternal Cardiac Disease: a historical perspective. The Parturient with Cardiac Disease 9/21/2012

More History. Organization. Maternal Cardiac Disease: a historical perspective. The Parturient with Cardiac Disease 9/21/2012 The Parturient with Cardiac Disease Pamela Flood M.D. Professor of Anesthesia and Perioperative Care Obstetrics, Gynecology and Reproductive Sciences University of California, San Francisco Maternal Cardiac

More information

Pregnancy and Heart Disease. Shilpa Kshatriya, MD, FACC Heartland Cardiology, PA

Pregnancy and Heart Disease. Shilpa Kshatriya, MD, FACC Heartland Cardiology, PA Pregnancy and Heart Disease Shilpa Kshatriya, MD, FACC Heartland Cardiology, PA Pregnancy and the Heart 2 % of pregnancies involve maternal CV disease CV disease does not preclude pregnancy but poses risk

More information

Outline. Maternal Congenital Heart Disease in Pregnancy. Maternal congenital heart disease. Cardiovascular disease in pregnancy 10/18/2017

Outline. Maternal Congenital Heart Disease in Pregnancy. Maternal congenital heart disease. Cardiovascular disease in pregnancy 10/18/2017 I have no disclosures or conflicts of interest to report. Maternal Congenital Heart Disease in Pregnancy Jennifer A. Jolley, MD Associate Clinical Professor University of California, Irvine Department

More information

Pregnancy and Heart Disease Sharon L. Roble, MD Echo Hawaii 2016

Pregnancy and Heart Disease Sharon L. Roble, MD Echo Hawaii 2016 1 Pregnancy and Heart Disease Sharon L. Roble, MD Echo Hawaii 2016 DISCLOSURES I have no disclosures relevant to today s talk 2 Cardiovascular Effects of Pregnancy Anatomic Ventricular muscle mass increases

More information

Clinicians and Facilities: RESOURCES WHEN CARING FOR WOMEN WITH ADULT CONGENITAL HEART DISEASE OR OTHER FORMS OF CARDIOVASCULAR DISEASE!!

Clinicians and Facilities: RESOURCES WHEN CARING FOR WOMEN WITH ADULT CONGENITAL HEART DISEASE OR OTHER FORMS OF CARDIOVASCULAR DISEASE!! Clinicians and Facilities: RESOURCES WHEN CARING FOR WOMEN WITH ADULT CONGENITAL HEART DISEASE OR OTHER FORMS OF CARDIOVASCULAR DISEASE!! Abha'Khandelwal,'MD,'MS' 'Stanford'University'School'of'Medicine'

More information

UC SF DISCLOSURES MANAGEMENT OF MATERNAL CONGENITAL HEART DISEASE OBJECTIVES. No financial disclosures CARDIOVASCULAR CHANGES ANTEPARTUM 6/10/2011

UC SF DISCLOSURES MANAGEMENT OF MATERNAL CONGENITAL HEART DISEASE OBJECTIVES. No financial disclosures CARDIOVASCULAR CHANGES ANTEPARTUM 6/10/2011 DISCLOSURES MANAGEMENT OF MATERNAL CONGENITAL HEART DISEASE No financial disclosures UC SF Lena H. Kim, MD AIM CONFERENCE June 10, 2011 spicecomments.com OBJECTIVES Physiologic cardiovascular changes of

More information

PREGNANCY AND CONGENITAL HEART DISEASE

PREGNANCY AND CONGENITAL HEART DISEASE PREGNANCY AND CONGENITAL HEART DISEASE SIDDHARTH JADHAV M.D. Assistant Professor of Radiology E.B. Singleton Department of Pediatric Radiology Texas Children's Hospital COMMERCIAL DISCLOSURE - None Objectives

More information

Valve Disease in the Pregnant Patient

Valve Disease in the Pregnant Patient Valve Disease in the Pregnant Patient Julie B. Damp, MD December 6, 2012 VanderbiltHeart.com If single, do not allow marriage. If fertile, do not allow pregnancy. If pregnant, do not allow delivery. If

More information

EVALUATION OF PREGNANT PATIENTS WITH HEART DISEASE. Karen Stout, MD University of Washington Seattle Children s Seattle, WA

EVALUATION OF PREGNANT PATIENTS WITH HEART DISEASE. Karen Stout, MD University of Washington Seattle Children s Seattle, WA EVALUATION OF PREGNANT PATIENTS WITH HEART DISEASE Karen Stout, MD University of Washington Seattle Children s Seattle, WA CASE PRESENTATION 24 year old woman with aortic regurgitation referred for evaluation

More information

Congenital Heart Disease Patient and Pregnancy

Congenital Heart Disease Patient and Pregnancy Congenital Heart Disease Patient and Pregnancy Gurur Biliciler-Denktas, M.D. Assistant Professor Division of Pediatric Cardiology, Department of Pediatrics The University of Texas Health Science Center

More information

Pregnancy and Heart Disease

Pregnancy and Heart Disease Pregnancy and Heart Disease Heidi M. Connolly, MD No disclosures 2011 MFMER 3138928-1 Regitz-Zagrosek V, Lundqvist C, Borghi C, et al. Pregnancy and the Heart 2% of pregnancies involve maternal CV disease

More information

Cardiac Disease in Pregnancy

Cardiac Disease in Pregnancy Cardiac Disease in Pregnancy DATE: SEPTEMBER 11, 2016 PRESENTED BY: ABIGAIL KHAN, MD Outline Scope of the problem Physiology of pregnancy Cardiac risk in pregnancy Pregnancy management Contraception 1

More information

Miscellaneous Cardiology Topics pregnancy - congenital - myocarditis - pericardial disease. Pregnancy and Cardiovascular Disease MCQ

Miscellaneous Cardiology Topics pregnancy - congenital - myocarditis - pericardial disease. Pregnancy and Cardiovascular Disease MCQ Miscellaneous Cardiology Topics pregnancy - congenital - myocarditis - pericardial disease Maan Jokhadar, MD, FACC Emory Center for Advanced Heart Failure Therapy Emory Adult Congenital Heart Center Pregnancy

More information

Nothing to Disclose. Severe Pulmonary Hypertension

Nothing to Disclose. Severe Pulmonary Hypertension Severe Ronald Pearl, MD, PhD Professor and Chair Department of Anesthesiology Stanford University Rpearl@stanford.edu Nothing to Disclose 65 year old female Elective knee surgery NYHA Class 3 Aortic stenosis

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Acid base balance pregnancy-related changes to, 640 Acquired heart disease, 731 Acute fatty liver of pregnancy (AFLP), 618 Acute kidney

More information

Uptofate Study Summary

Uptofate Study Summary CONGENITAL HEART DISEASE Uptofate Study Summary Acyanotic Atrial septal defect Ventricular septal defect Patent foramen ovale Patent ductus arteriosus Aortic coartation Pulmonary stenosis Cyanotic Tetralogy

More information

Ejection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV.

Ejection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV. Valvular Heart Disease Etiology General Principles Cellular and molecular mechanism of valve damage Structural pathology Functional pathology - stenosis/regurgitation Loading conditions - pressure/volume

More information

Peripartum Cardiomyopathy. Lavanya Rai Manipal

Peripartum Cardiomyopathy. Lavanya Rai Manipal Peripartum Cardiomyopathy Lavanya Rai Manipal Definition - PPCM - Dilated cardiomyopathy of unknown cause resulting in cardiac failure that occurs in the peripartum period in women without any preexisting

More information

Ejection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV.

Ejection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV. Valvular Heart Disease General Principles Etiology Cellular and molecular mechanism of valve damage Structural pathology Functional pathology - stenosis/regurgitation Loading conditions - pressure/volume

More information

Cardiac disease in pre pr gnancy

Cardiac disease in pre pr gnancy IN THE NAME OF GOD Cardiac disease in pregn nancy MITRAL STENOSIS 33 y/o G3L2(2c/s) GA 34 + 5 CC: LP & dyspnea PMHx: MS sinse 4 yrs ago due to Rheumatism PSHx: 2c/s DHx: metoral 50 mg q6h/ ASA/ Enoxaparin

More information

Pregnancy and Heart Disease. Alexandra A Frogoudaki Adult Congenital Heart Clinic ATTIKON University Hospital

Pregnancy and Heart Disease. Alexandra A Frogoudaki Adult Congenital Heart Clinic ATTIKON University Hospital Pregnancy and Heart Disease Alexandra A Frogoudaki Adult Congenital Heart Clinic ATTIKON University Hospital Pregnancy is not a state Hemodynamic changes During pregnancy Estrogens 1. Renin 2.

More information

Adult Echocardiography Examination Content Outline

Adult Echocardiography Examination Content Outline Adult Echocardiography Examination Content Outline (Outline Summary) # Domain Subdomain Percentage 1 2 3 4 5 Anatomy and Physiology Pathology Clinical Care and Safety Measurement Techniques, Maneuvers,

More information

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A ACHD. See Adult congenital heart disease (ACHD) Adult congenital heart disease (ACHD), 503 512 across life span prevalence of, 504 506

More information

Anatomy & Physiology

Anatomy & Physiology 1 Anatomy & Physiology Heart is divided into four chambers, two atrias & two ventricles. Atrioventricular valves (tricuspid & mitral) separate the atria from ventricles. they open & close to control flow

More information

Maternal Cardiac Disease Diagnosis and Management

Maternal Cardiac Disease Diagnosis and Management Maternal Cardiac Disease Diagnosis and Management Dr. Şevki ÇELEN ZTB Maternity and Teaching Hospital Department of Perinatology Heart diseases in pregnancy Today, 0.2-4% of all pregnancies are accompanied

More information

Cardiovascular disease complicates 1% to 3% of all

Cardiovascular disease complicates 1% to 3% of all Pregnancy Complicated by Valvular Heart Disease: An Update Michael Nanna, MD; Kathleen Stergiopoulos, MD, PhD, FASE, FACC, FAHA Cardiovascular disease complicates 1% to 3% of all pregnancies and is responsible

More information

Management of Heart Failure and Cardiomyopathies in Pregnancy

Management of Heart Failure and Cardiomyopathies in Pregnancy Management of Heart Failure and Cardiomyopathies in Pregnancy Professor Sanjay Sharma Disclosures: None Epidemiology of Cardiac Disease In Pregnancy Cardiovascular disease in pregnancy is increasing in

More information

Critical Care in Obstetrics: An Innovative and Integrated Model for Learning the Essentials

Critical Care in Obstetrics: An Innovative and Integrated Model for Learning the Essentials Critical Care in Obstetrics: An Innovative and Integrated Model for Learning the Essentials Pregnancy and Congenital Heart Disease Case Review Heidi M. Connolly, M.D. Professor of Medicine Chair for Education

More information

Έγκυος και συγγενής καρδιοπάθεια: Τι πρέπει να γνωρίζει ο Καρδιολόγος Ενηλίκων

Έγκυος και συγγενής καρδιοπάθεια: Τι πρέπει να γνωρίζει ο Καρδιολόγος Ενηλίκων Έγκυος και συγγενής καρδιοπάθεια: Τι πρέπει να γνωρίζει ο Καρδιολόγος Ενηλίκων Αντώνιος Π. Βλάχος Αναπληρωτής Καθηγητής Παιδοκαρδιολογίας Πανεπιστήμιο Ιωαννίνων No conflict of interest Pregnancy and CHD

More information

RF & RHD Workshop 22 nd March MANAGEMENT of RHEUMATIC HEART DISEASE in PREGNANCY. Dr Dorothy Radford

RF & RHD Workshop 22 nd March MANAGEMENT of RHEUMATIC HEART DISEASE in PREGNANCY. Dr Dorothy Radford RF & RHD Workshop 22 nd March 2016 MANAGEMENT of RHEUMATIC HEART DISEASE in PREGNANCY Dr Dorothy Radford PREGNANCY PHYSIOLOGY Increased cardiac output 30%-50% Increased blood volume 30%-50% Increased heart

More information

Susan P. D Anna MSN, APRN BC February 14, 2019

Susan P. D Anna MSN, APRN BC February 14, 2019 Is there Equal Opportunity in Heart Failure?? Susan P. D Anna MSN, APRN BC February 14, 2019 Disclosures: I have no financial disclosures. I am not an expert on this topic, but see a lot of women with

More information

European CMR Certification: LIST OF PROCEDURES FORM

European CMR Certification: LIST OF PROCEDURES FORM European CMR Certification: LIST OF PROCEDURES FORM Application for: Level 2 Level 3 Candidate is requested to submit a list of 150 (Level 2) or 300 (Level 3) studies reported by her/him as detailed in

More information

Pregnancy and Cardiovascular Disease

Pregnancy and Cardiovascular Disease Pregnancy and Cardiovascular Disease Cindy M. Martin, M.D. Co-Director, Adult Congenital and Cardiovascular Genetics Center No Disclosures Objectives Discuss the hemodynamic changes during pregnancy Define

More information

How to manage the pregnant woman with heart disease

How to manage the pregnant woman with heart disease How to manage the pregnant woman with heart disease Dr Fiona Walker, The Heart Hospital,UCLH, London Dr Sara Thorne, University Hospital Birmingham Dr Cathy Head, The Heart Hospital, UCLH, London Dr Kate

More information

Heart Failure. Cardiac Anatomy. Functions of the Heart. Cardiac Cycle/Hemodynamics. Determinants of Cardiac Output. Cardiac Output

Heart Failure. Cardiac Anatomy. Functions of the Heart. Cardiac Cycle/Hemodynamics. Determinants of Cardiac Output. Cardiac Output Cardiac Anatomy Heart Failure Professor Qing ZHANG Department of Cardiology, West China Hospital www.blaufuss.org Cardiac Cycle/Hemodynamics Functions of the Heart Essential functions of the heart to cover

More information

ESC Guidelines on the Management of Cardiovascular Diseases during Pregnancy

ESC Guidelines on the Management of Cardiovascular Diseases during Pregnancy ESC Guidelines on the Management of Cardiovascular Diseases during Pregnancy Task force on the management of CVD during pregnancy of the ESC Chair: Vera Regitz-Zagrosek, Charite, Berlin None DECLARATION

More information

Hemodynamic Monitoring

Hemodynamic Monitoring Perform Procedure And Interpret Results Hemodynamic Monitoring Tracheal Tube Cuff Pressure Dean R. Hess PhD RRT FAARC Hemodynamic Monitoring Cardiac Rate and Rhythm Arterial Blood Pressure Central Venous

More information

Congenital Heart Disease

Congenital Heart Disease Congenital Heart Disease Mohammed Alghamdi, MD, FRCPC, FAAP, FACC Associate Professor and Consultant Pediatric Cardiology, Cardiac Science King Fahad Cardiac Centre King Saud University INTRODUCTION CHD

More information

FUNDAMENTALS OF HEMODYNAMICS, VASOACTIVE DRUGS AND IABP IN THE FAILING HEART

FUNDAMENTALS OF HEMODYNAMICS, VASOACTIVE DRUGS AND IABP IN THE FAILING HEART FUNDAMENTALS OF HEMODYNAMICS, VASOACTIVE DRUGS AND IABP IN THE FAILING HEART CINDY BITHER, MSN, ANP, ANP, AACC, CHFN CHIEF NP, ADV HF PROGRAM MEDSTAR WASHINGTON HOSPITAL CENTER CONFLICTS OF INTEREST NONE

More information

Καρδιοπάθειες και κύηση. Υπάρχουν ενδείξεις διακοπής; Λαζαρίδου Φωτεινή, ΕΒ Καρδιολόγος Νοσοκομείο «Αγ Παύλος», Θεσσαλονίκη

Καρδιοπάθειες και κύηση. Υπάρχουν ενδείξεις διακοπής; Λαζαρίδου Φωτεινή, ΕΒ Καρδιολόγος Νοσοκομείο «Αγ Παύλος», Θεσσαλονίκη Καρδιοπάθειες και κύηση. Υπάρχουν ενδείξεις διακοπής; Λαζαρίδου Φωτεινή, ΕΒ Καρδιολόγος Νοσοκομείο «Αγ Παύλος», Θεσσαλονίκη ~ 3% of women 18 44 years of age have cardiac disease ~ 1% of pregnancies are

More information

Physical Exam Part II

Physical Exam Part II Physical Exam Part II University of Michigan Cardiovascular Center Kim A. Eagle, MD Albion Walter Hewlett Professor Director Physical Exam: Part II Heart Sounds Heart Murmurs HEART SOUNDS S1 MITRAL + TRICUSPID

More information

CASE DISCUSSION. Dr JAYASREE VEERABOINA 2nd yr PG MS OBG

CASE DISCUSSION. Dr JAYASREE VEERABOINA 2nd yr PG MS OBG CASE DISCUSSION Dr JAYASREE VEERABOINA 2nd yr PG MS OBG Normal Cardiovascular changes in Pregnancy CARDIAC OUTPUT 5 th wk -- starts 12 wks -- 30-35% 30-32 wks -- 40% During labour -- 50% After delivery

More information

Rate of CHD at birth: 4~12/1,000

Rate of CHD at birth: 4~12/1,000 Risk assessment and management for the pregnant ACHD woman Suk-Joo Choi Department of Obstetrics and Gynecology Samsung Medical Center Sungkyunkwan k University i School of Medicine i Cardiac diseases

More information

Pre-discussion questions

Pre-discussion questions Amanda Bartlett, PA-C Dustin Bartlett, PA-C Andrea Applegate, PA-C Leslie Yearta Brown, NP CHF Round Table Discussion Objectives ANDREA- Discuss the definition and different categories of CHF DUSTIN- Define

More information

Valvular Heart Disease Mitral Stenosis

Valvular Heart Disease Mitral Stenosis Valvular Heart Disease Mitral Stenosis A 75 year old woman with loud first heart sound and mid-diastolic murmur Chronic dyspnea Class 2/4 Fatigue Recent orthopnea/pnd Nocturnal palpitation Pedal edema

More information

Innovation therapy in Heart Failure

Innovation therapy in Heart Failure Innovation therapy in Heart Failure P. Laothavorn September 2015 Topics of discussion Basic Knowledge about heart failure Standard therapy New emerging therapy References: standard Therapy in Heart Failure

More information

ADULT CONGENITAL HEART DISEASE. Stuart Lilley

ADULT CONGENITAL HEART DISEASE. Stuart Lilley ADULT CONGENITAL HEART DISEASE Stuart Lilley More adults than children have congenital heart disease Huge variety of congenital lesions from minor to major Heart failure, re-operation and arrhythmia are

More information

Maternal and Fetal Physiology

Maternal and Fetal Physiology Background Maternal and Fetal Physiology Anderson Lo, DO Fellow, Maternal-Fetal Medicine Wayne State University School of Medicine SEMCME Fetal Assessment Course July 20, 2018 Oxygen pathway Mother Placenta

More information

PERIPARTUM CARDIOMYOPATHY

PERIPARTUM CARDIOMYOPATHY PERIPARTUM CARDIOMYOPATHY Dr.T.Venkatachalam. Professor of Anaesthesiology Madras Medical College, Chennai Peripartum cardiomyopathy is defined as the onset of acute heart failure without demonstrable

More information

Hypertension in Aortic Valve Disease

Hypertension in Aortic Valve Disease Hypertension in Aortic Valve Disease Hanna M. Nosseir MRCP, FRCP Head of Cardiology department Galaa Military Medical Complex Aortic stenosis: Introduction Arterial hypertension and aortic stenosis are

More information

Closing ASDs with pulmonary hypertension. Shakeel A Qureshi Evelina Children s Hospital London

Closing ASDs with pulmonary hypertension. Shakeel A Qureshi Evelina Children s Hospital London Closing ASDs with pulmonary hypertension Shakeel A Qureshi Evelina Children s Hospital London Ho Chi Minh, Vietnam, January 2012 ACC/AHA 2008 Guidelines ASD closure Closure is indicated for right atrial

More information

Echocardiography as a diagnostic and management tool in medical emergencies

Echocardiography as a diagnostic and management tool in medical emergencies Echocardiography as a diagnostic and management tool in medical emergencies Frank van der Heusen MD Department of Anesthesia and perioperative Care UCSF Medical Center Objective of this presentation Indications

More information

Pathophysiology: Heart Failure

Pathophysiology: Heart Failure Pathophysiology: Heart Failure Mat Maurer, MD Irving Assistant Professor of Medicine Outline Definitions and Classifications Epidemiology Muscle and Chamber Function Pathophysiology Heart Failure: Definitions

More information

The Causes of Heart Failure

The Causes of Heart Failure The Causes of Heart Failure Andy Birchall HFSN Right heart failure LVSD - HFREF Valve regurgitation or stenosis Dropsy CCF congestive cardiac failure Cor pulmonale Pulmonary hypertension HFPEF LVF Definitions

More information

Valvular Heart Disease. Dr. HANAN ALBACKR

Valvular Heart Disease. Dr. HANAN ALBACKR Valvular Heart Disease Dr. HANAN ALBACKR Valvular Heart Disease Format for this lecture IMPORTANT CLINICAL INFO know for boards, tests and clinical practice Spectrum of VHD Aortic Valve Mitral Valve Tricuspid

More information

What to do when a heart failure patient becomes pregnant

What to do when a heart failure patient becomes pregnant BSH Heart Failure Day for Revalidation and Training 2017 What to do when a heart failure patient becomes pregnant Dr Diane Barker Consultant Cardiologist Royal Stoke Hospital Conflicts of interest - sponsorship,

More information

The Ross Procedure: Outcomes at 20 Years

The Ross Procedure: Outcomes at 20 Years The Ross Procedure: Outcomes at 20 Years Tirone David Carolyn David Anna Woo Cedric Manlhiot University of Toronto Conflict of Interest None The Ross Procedure 1990 to 2004 212 patients: 66% 34% Mean age:

More information

Pathophysiology: Left To Right Shunts

Pathophysiology: Left To Right Shunts Pathophysiology: Left To Right Shunts Daphne T. Hsu, MD dh17@columbia.edu Learning Objectives Learn the relationships between pressure, blood flow, and resistance Review the transition from fetal to mature

More information

Pregnancy, Heart Disease and Imaging. Hemodynamics. Decreased systemic vascular resistance. Physiology anemia

Pregnancy, Heart Disease and Imaging. Hemodynamics. Decreased systemic vascular resistance. Physiology anemia Pregnancy, Heart Disease and Imaging Sangeeta Shah, MD, FASE, FACC Associate Professor, Ochsner Clinical School of Medicine Advanced CV Imaging and Adult Congenital Heart Disease New Orleans, LA Hemodynamics

More information

Heart disease complicating pregnancy management strategies

Heart disease complicating pregnancy management strategies www.slcog.lk/sljog LEADING ARTICLE Heart disease complicating pregnancy management strategies Priyadharshan P¹ Introduction Heart disease is the third most common cause of maternal death and the leading

More information

Echocardiography in Adult Congenital Heart Disease

Echocardiography in Adult Congenital Heart Disease Echocardiography in Adult Congenital Heart Disease Michael Vogel Kinderherz-Praxis München CHD missed in childhood Subsequent lesions after repaired CHD Follow-up of cyanotic heart disease CHD missed in

More information

Effect of maternal heart disease on pregnancy outcomes

Effect of maternal heart disease on pregnancy outcomes Expert Review of Obstetrics & Gynecology ISSN: 1747-4108 (Print) 1747-4116 (Online) Journal homepage: http://www.tandfonline.com/loi/ierb20 Effect of maternal heart disease on pregnancy outcomes Emily

More information

Pathophysiology: Left To Right Shunts

Pathophysiology: Left To Right Shunts Pathophysiology: Left To Right Shunts Daphne T. Hsu, MD dh17@columbia.edu Learning Objectives Learn the relationships between pressure, blood flow, and resistance Review the transition from fetal to mature

More information

Outline. Pathophysiology: Heart Failure. Heart Failure. Heart Failure: Definitions. Etiologies. Etiologies

Outline. Pathophysiology: Heart Failure. Heart Failure. Heart Failure: Definitions. Etiologies. Etiologies Outline Pathophysiology: Mat Maurer, MD Irving Assistant Professor of Medicine Definitions and Classifications Epidemiology Muscle and Chamber Function Pathophysiology : Definitions An inability of the

More information

TSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD

TSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD TSDA Boot Camp September 13-16, 2018 Introduction to Aortic Valve Surgery George L. Hicks, Jr., MD Aortic Valve Pathology and Treatment Valvular Aortic Stenosis in Adults Average Course (Post mortem data)

More information

Diagnosis & Management of Heart Failure. Abena A. Osei-Wusu, M.D. Medical Fiesta

Diagnosis & Management of Heart Failure. Abena A. Osei-Wusu, M.D. Medical Fiesta Diagnosis & Management of Heart Failure Abena A. Osei-Wusu, M.D. Medical Fiesta Learning Objectives: 1) Become familiar with pathogenesis of congestive heart failure. 2) Discuss clinical manifestations

More information

Valvular heart disease : Role of medication ( drug and intervention ) Pol.Col.Dr.Kasem Ratanasumawong

Valvular heart disease : Role of medication ( drug and intervention ) Pol.Col.Dr.Kasem Ratanasumawong Valvular heart disease : Role of medication ( drug and intervention ) Pol.Col.Dr.Kasem Ratanasumawong Management of valvular heart disease Accurate diagnosis and disease severity Prevention and treatment

More information

M2 TEACHING UNDERSTANDING PHARMACOLOGY

M2 TEACHING UNDERSTANDING PHARMACOLOGY M2 TEACHING UNDERSTANDING PHARMACOLOGY USING CVS SYSTEM AS AN EXAMPLE NIGEL FONG 2 JAN 2014 TODAY S OBJECTIVE Pharmacology often seems like an endless list of mechanisms and side effects to memorize. To

More information

Policy REVISED: 6/30/2016 3:30 PM. Applies To: ObGyn Responsible Department: ObGyn Revised: June 30, 2016

Policy REVISED: 6/30/2016 3:30 PM. Applies To: ObGyn Responsible Department: ObGyn Revised: June 30, 2016 Title: Antihypertensive Treatment for Severe Hypertension During Pregnancy Applies To: ObGyn Responsible Department: ObGyn Revised: June 30, 2016 Policy POLICY STATEMENT: Pregnant or postpartum patients

More information

Catherine Nelson-Piercy. Guy s & St Thomas Hospitals & Queen Charlotte s Hospital London, UK

Catherine Nelson-Piercy. Guy s & St Thomas Hospitals & Queen Charlotte s Hospital London, UK Cardiac Disease and Pregnancy Catherine Nelson-Piercy Guy s & St Thomas Hospitals & Queen Charlotte s Hospital London, UK Physiological changes in pregnancy Cardiac Output (CO) increases by 40% Further

More information

Cardiomyopathy. Jeff Grubbe MD FACP, Chief Medical Director, Allstate Life & Retirement

Cardiomyopathy. Jeff Grubbe MD FACP, Chief Medical Director, Allstate Life & Retirement Cardiomyopathy Jeff Grubbe MD FACP, Chief Medical Director, Allstate Life & Retirement Nebraska Home Office Life Underwriters Association March 20, 2018 1 Cardiomyopathy A myocardial disorder in which

More information

Steel vs Alcohol. Or Neither. Management of Hypertrophic Cardiomyopathy. Josh Doll, MD January 24, 2015

Steel vs Alcohol. Or Neither. Management of Hypertrophic Cardiomyopathy. Josh Doll, MD January 24, 2015 Steel vs Alcohol Or Neither Management of Hypertrophic Cardiomyopathy Josh Doll, MD January 24, 2015 47yo Male, Mr. L Severe progressive dyspnea on exertion and weight gain Previous avid Cross-Fit participant

More information

Is it HF secondary to rheumatic heart disease???

Is it HF secondary to rheumatic heart disease??? Is it HF secondary to rheumatic heart disease??? Is mitral regurg. Is complication of CHF??? Cardiomyopathy Definition The term cardiomyopathy is purely descriptive, meaning disease of the heart muscle

More information

Critical Care in Obstetrics: An Innovative and Integrated Model for Learning the Essentials

Critical Care in Obstetrics: An Innovative and Integrated Model for Learning the Essentials Critical Care in Obstetrics: An Innovative and Integrated Model for Learning the Essentials Pregnancy and Congenital Heart Disease Heidi M. Connolly, M.D. Professor of Medicine Chair for Education Division

More information

Echo Doppler Assessment of Right and Left Ventricular Hemodynamics.

Echo Doppler Assessment of Right and Left Ventricular Hemodynamics. Echo Doppler Assessment of Right and Left Ventricular Hemodynamics. Itzhak Kronzon, MD, FASE, FACC, FESC, FAHA, FACP, FCCP Northwell, Lenox Hill Hospital, New York Professor of Cardiology Hofstra University

More information

Index of subjects. effect on ventricular tachycardia 30 treatment with 101, 116 boosterpump 80 Brockenbrough phenomenon 55, 125

Index of subjects. effect on ventricular tachycardia 30 treatment with 101, 116 boosterpump 80 Brockenbrough phenomenon 55, 125 145 Index of subjects A accessory pathways 3 amiodarone 4, 5, 6, 23, 30, 97, 102 angina pectoris 4, 24, 1l0, 137, 139, 140 angulation, of cavity 73, 74 aorta aortic flow velocity 2 aortic insufficiency

More information

Mitral Valve Disease. Prof. Sirchak Yelizaveta Stepanovna

Mitral Valve Disease. Prof. Sirchak Yelizaveta Stepanovna Mitral Valve Disease Prof. Sirchak Yelizaveta Stepanovna Fall 2008 Mitral Valve Stenosis Lecture Outline Mitral Stenosis Mitral Regurgitation Etiology Pathophysiology Clinical features Diagnostic testing

More information

Candice Silversides, MD Toronto Congenital Cardiac Centre for Adults University of Toronto Toronto, Canada

Candice Silversides, MD Toronto Congenital Cardiac Centre for Adults University of Toronto Toronto, Canada PVR Following Repair of TOF Now? When? Candice Silversides, MD Toronto Congenital Cardiac Centre for Adults University of Toronto Toronto, Canada Late Complications after TOF repair Repair will be necessary

More information

E/Ea is NOT an essential estimator of LV filling pressures

E/Ea is NOT an essential estimator of LV filling pressures Euroecho Kopenhagen Echo in Resynchronization in 2010 E/Ea is NOT an essential estimator of LV filling pressures Wilfried Mullens, MD, PhD December 10, 2010 Ziekenhuis Oost Limburg Genk University Hasselt

More information

Heart Failure. Dr. William Vosik. January, 2012

Heart Failure. Dr. William Vosik. January, 2012 Heart Failure Dr. William Vosik January, 2012 Questions for clinicians to ask Is this heart failure? What is the underlying cause? What are the associated disease processes? Which evidence-based treatment

More information

MITRAL VALVE DISEASE- ASSESSMENT AND MANAGEMENT. Irene Frantzis P year, SGUL Sheba Medical Center

MITRAL VALVE DISEASE- ASSESSMENT AND MANAGEMENT. Irene Frantzis P year, SGUL Sheba Medical Center MITRAL VALVE DISEASE- ASSESSMENT AND MANAGEMENT Irene Frantzis P year, SGUL Sheba Medical Center MITRAL VALVE DISEASE Mitral Valve Regurgitation Mitral Valve Stenosis Mitral Valve Prolapse MITRAL REGURGITATION

More information

Focused. se with 2008 F. lar Heart Diseas. date. ents With Valvul. Upd. gement of Patie. lines for Manag. HA 2006 Guidel ACC/AH. Fig.

Focused. se with 2008 F. lar Heart Diseas. date. ents With Valvul. Upd. gement of Patie. lines for Manag. HA 2006 Guidel ACC/AH. Fig. ACC/AH HA 2006 Guidel nic severe AI (Fig. 4). ned by age, ay also be helpful nd echo. For AI, ollow up may be or MRI rather than mension; SD, end lines for Manag gement of Patie Upd ents With Valvul date

More information

Cardiac Emergencies in Infants. Michael Luceri, DO

Cardiac Emergencies in Infants. Michael Luceri, DO Cardiac Emergencies in Infants Michael Luceri, DO October 7, 2017 I have no financial obligations or conflicts of interest to disclose. Objectives Understand the scope of congenital heart disease Recognize

More information

Congestive Heart Failure Patient Profile. Patient Identity - Mr. Douglas - 72 year old man - No drugs, smokes, moderate social alcohol consumption

Congestive Heart Failure Patient Profile. Patient Identity - Mr. Douglas - 72 year old man - No drugs, smokes, moderate social alcohol consumption Congestive Heart Failure Patient Profile Patient Identity - Mr. Douglas - 72 year old man - No drugs, smokes, moderate social alcohol consumption Chief Complaint - SOB - When asked: Increasing difficulty

More information

CARDIAC DISEASE IN PREGNANCY: TUTORIAL 2 TUTORIAL OF THE WEEK TH NOVEMBER 2008

CARDIAC DISEASE IN PREGNANCY: TUTORIAL 2 TUTORIAL OF THE WEEK TH NOVEMBER 2008 CARDIAC DISEASE IN PREGNANCY: TUTORIAL 2 TUTORIAL OF THE WEEK 118 10 TH NOVEMBER 2008 Dr. Abbi Walker, Christchurch Hospital, New Zealand Dr. Matt Rucklidge, Royal Devon & Exeter Hospital, UK mattrucklidge@yahoo.co.uk

More information

Adult Congenital Heart Disease: A Growing Problem. Dr. Gary Webb Cincinnati Children s Hospital Heart Institute

Adult Congenital Heart Disease: A Growing Problem. Dr. Gary Webb Cincinnati Children s Hospital Heart Institute Adult Congenital Heart Disease: A Growing Problem Dr. Gary Webb Cincinnati Children s Hospital Heart Institute ACHD Resources in Ohio ACHAHEART.ORG Situations When We Might Help When you don t know a

More information

Definition of Congestive Heart Failure

Definition of Congestive Heart Failure Heart Failure Definition of Congestive Heart Failure A clinical syndrome of signs & symptoms resulting from the heart s inability to supply adequate tissue perfusion. CHF Epidemiology Affects 4.7 million

More information

Peripartum management of Rheumatic Heart Disease

Peripartum management of Rheumatic Heart Disease Peripartum management of Rheumatic Heart Disease Dr James Sartain Director of Anaesthesia & Perioperative Medicine Cairns & Hinterland Hospital & Health Service Talk outline Why (still) talk about RHD

More information

S. Bruce Greenberg, MD FNASCI and President, NASCI Professor of Radiology and Pediatrics University of Arkansas for Medical Sciences

S. Bruce Greenberg, MD FNASCI and President, NASCI Professor of Radiology and Pediatrics University of Arkansas for Medical Sciences S. Bruce Greenberg, MD FNASCI and President, NASCI Professor of Radiology and Pediatrics University of Arkansas for Medical Sciences No financial disclosures Aorta Congenital aortic stenosis/insufficiency

More information

Detailed Order Request Checklists for Cardiology

Detailed Order Request Checklists for Cardiology Next Generation Solutions Detailed Order Request Checklists for Cardiology 8600 West Bryn Mawr Avenue South Tower Suite 800 Chicago, IL 60631 www.aimspecialtyhealth.com Appropriate.Safe.Affordable 2018

More information

Heart Failure. Subjective SOB (shortness of breath) Peripheral edema. Orthopnea (2-3 pillows) PND (paroxysmal nocturnal dyspnea)

Heart Failure. Subjective SOB (shortness of breath) Peripheral edema. Orthopnea (2-3 pillows) PND (paroxysmal nocturnal dyspnea) Pharmacology I. Definitions A. Heart Failure (HF) Heart Failure Ezra Levy, Pharm.D. HF Results when one or both ventricles are unable to pump sufficient blood to meet the body s needs There are 2 types

More information

University of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives

University of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives University of Florida Department of Surgery CardioThoracic Surgery VA Learning Objectives This service performs coronary revascularization, valve replacement and lung cancer resections. There are 2 faculty

More information

Pulmonary Hypertension: Another Use for Viagra

Pulmonary Hypertension: Another Use for Viagra Pulmonary Hypertension: Another Use for Viagra Kathleen Tong, MD Director, Heart Failure Program Assistant Clinical Professor University of California, Davis Disclosures I have no financial conflicts A

More information

Physiologic Based Management of Circulatory Shock Kuwait 2018

Physiologic Based Management of Circulatory Shock Kuwait 2018 Physiologic Based Management of Circulatory Shock Kuwait 2018 Dr. Yasser Elsayed, MD, PhD Director of the Targeted Neonatal Echocardiography, Point of Care and Hemodynamics Program Staff Neonatologist

More information

Right-Sided Congestive Heart Failure Basics

Right-Sided Congestive Heart Failure Basics Right-Sided Congestive Heart Failure Basics OVERVIEW Failure of the right side of the heart to pump blood at a sufficient rate to meet the needs of the body or to prevent blood from pooling within the

More information

MRI (AND CT) FOR REPAIRED TETRALOGY OF FALLOT

MRI (AND CT) FOR REPAIRED TETRALOGY OF FALLOT MRI (AND CT) FOR REPAIRED TETRALOGY OF FALLOT Linda B Haramati MD, MS Departments of Radiology and Medicine Bronx, New York OUTLINE Pathogenesis Variants Initial surgical treatments Basic MR protocols

More information

Impedance Cardiography (ICG) Application of ICG for Hypertension Management

Impedance Cardiography (ICG) Application of ICG for Hypertension Management Application of ICG for Hypertension Management 1mA @ 100 khz Impedance Cardiography (ICG) Non-invasive Beat-to-beat Hemodynamic Monitoring Diastole Systole Aortic valve is closed No blood flow in the aorta

More information

Impedance Cardiography (ICG) Application of ICG in Intensive Care and Emergency

Impedance Cardiography (ICG) Application of ICG in Intensive Care and Emergency Impedance Cardiography (ICG) Application of ICG in Intensive Care and Emergency Aim of haemodynamic monitoring in ICU and ED Detection and therapy of insufficient organ perfusion Answers to common cardiovascular

More information

Introduction. Invasive Hemodynamic Monitoring. Determinants of Cardiovascular Function. Cardiovascular System. Hemodynamic Monitoring

Introduction. Invasive Hemodynamic Monitoring. Determinants of Cardiovascular Function. Cardiovascular System. Hemodynamic Monitoring Introduction Invasive Hemodynamic Monitoring Audis Bethea, Pharm.D. Assistant Professor Therapeutics IV January 21, 2004 Hemodynamic monitoring is necessary to assess and manage shock Information obtained

More information